ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 56

A Systems Biology Approach to Investigating Beneficial Effects of Endurance Exercise in Myositis Patients

Jessica Boehler1,2, Marshall Hogarth3, Matthew Barberio3, Svetlana Ghimbovschi2, Kristy Brown1,2, Li Alemo Munters4, Ingela Loell4, Yi-Wen Chen2,5, Helene Alexanderson6, Ingrid E. Lundberg7 and Kanneboyina Nagaraju5,8, 1Department of Integrative Systems Biology, The George Washington University, Washingtion, DC, 2Research Center for Genetic Medicine, Children's National Medical Center, Washington, DC, 3Research Center for Genetic Medicine, Children's National Medical Center, Washingtion, DC, 4Karolinska University Hospital, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Sweden, Stockholm, Sweden, 5Department of Integrative Systems Biology, The George Washington University, Washington, DC, 6Department of NVS, Division of Physical Therapy, Karolinska Institutet, Huddinge, Sweden, 7Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 8Research Center for Genetic Medicine, Children’s National Medical Center, Washington, DC

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: exercise and myositis, MicroRNA

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Genetics, Genomics and Proteomics - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Polymyositis (PM) and dermatomyositis (DM) are skeletal muscle disorders characterized by proximal muscle weakness and inflammation. Recent studies have suggested that endurance exercise improves disease activity in PM and DM by suppressing inflammation and promoting muscle growth through activation of an aerobic muscle phenotype. The molecular mechanisms underlying disease improvement are not fully understood. We hypothesized that endurance exercise induces alterations in skeletal muscle microRNAs that control genes and proteins relevant to disease pathogenesis.

Methods:  Patients, diagnosed as PM or DM according to the Bohan and Peter classification, were randomized into a 12-week endurance exercise group that consisted of cycling for 1 hour/3 times a week or a non-exercised control group. Muscle biopsies from the vastus lateralis were collected before and after the 12-week training program. MicroRNA expression profiling was determined using the Affymetrix platform, mRNA using the Illumina platform and proteomics using SuperSILAC mass spectrometry. Post intervention values were normalized to pre-intervention values and a t-test for unequal variance comparing exercised vs. control patients was used to determine significant changes (p<0.05). Ingenuity Pathway Analysis (IPA) MicroRNA Target Filter was used to identify gene targets. Gene expression profiling and proteomics were used to verify microRNA targets that were altered by exercise in the patients’ skeletal muscle. IPA Core Analysis was used to determine the function of significantly changed transcripts and proteins.

Results:  Endurance exercise differentially altered 188 microRNAs. Approximately one fourth of these microRNAs are predicted to target over 12,000 genes. We have found that endurance exercise alters microRNAs that affect various processes involved in the pathogenesis of myositis. MicroRNA-target transcripts altered after endurance exercise control genes that affect vasculature, inflammatory cells and skeletal muscle cells. We also found that anti-inflammatory, anti-fibrotic, and muscle regenerative and metabolic processes are affected favorably. MicroRNA-targeted proteomic analysis of these samples further confirmed that these pathways are altered at the protein level.

Conclusion:  To our knowledge, this is the first systems biology study investigating microRNA, and its regulation on mRNA and protein, before and after exercise in myositis patients. Identified microRNAs can serve as biomarkers to assess disease progression, as well as monitor responses to therapy.


Disclosure: J. Boehler, None; M. Hogarth, None; M. Barberio, None; S. Ghimbovschi, None; K. Brown, None; L. Alemo Munters, None; I. Loell, None; Y. W. Chen, None; H. Alexanderson, None; I. E. Lundberg, Bristol-Myers Squibb, 2,Bristol-Myers Squibb, 5,Idera, 5,AstraZeneca, 2,ATyr, 9; K. Nagaraju, None.

To cite this abstract in AMA style:

Boehler J, Hogarth M, Barberio M, Ghimbovschi S, Brown K, Alemo Munters L, Loell I, Chen YW, Alexanderson H, Lundberg IE, Nagaraju K. A Systems Biology Approach to Investigating Beneficial Effects of Endurance Exercise in Myositis Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/a-systems-biology-approach-to-investigating-beneficial-effects-of-endurance-exercise-in-myositis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-systems-biology-approach-to-investigating-beneficial-effects-of-endurance-exercise-in-myositis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology